MYCN and prostate adenocarcinoma: Several published studies have demonstrated a necessary role for N-MYC and c-MYC in regulating neuroendocrine transdifferentiation of prostate adenocarcinoma resulting in the formation of the aggressive neuroendocrine-differentiated subtype11, 12, 14, 27.